Publication Name	World Journal of Hepatology
Manuscript ID	15734
Country	China

Received	2014-12-06 15:16
Peer-Review Started	2014-12-06 22:47
To Make the First Decision	2015-01-20 13:41
Return for Revision	2015-01-20 17:48
Revised	2015-01-29 15:58
Second Decision	2015-02-10 16:25
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-02-12 15:06
Articles in Press	2015-02-12 15:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-05-05 17:03
Publish the Manuscript Online	2015-06-03 12:00

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Management of chronic hepatitis B before and after liver transplantation
Manuscript Source	Invited Manuscript
All Author List	James Fung
Funding Agency and Grant Number
Corresponding Author	James Fung, MD, Department of Medicine, Queen Mary Hospital, the University of Hong Kong, 102 Pokfulam Road, Hong Kong, China. jfung@gastro.hk
Key Words	Hepatitis B; Liver transplantation; Antiviral therapy; Prevention; Prophylaxis; Hepatitis B immune globulin
Core Tip	In the era of highly potent nucleoside and nucleotide analogues for the treatment of hepatitis B, long term viral suppression can be achieved with minimal risk of drug resistance. The use of these agents without hepatitis B immune globulin has been shown to be highly effective in preventing hepatitis B-related graft hepatitis, with excellent long-term outcome. Complete eradication of hepatitis B from the host however is unlikely, and long-term therapy is therefore required. Future developments aiming at different target sites together with immune restoration of the host against hepatitis B may make this elusive goal possible.
Publish Date	2015-06-03 12:00
Citation	Fung J. Management of chronic hepatitis B before and after liver transplantation. World J Hepatol 2015; 7(10): 1421-1426
URL	http://www.wjgnet.com/1948-5182/full/v7/i10/1421.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i10.1421

Full Article (PDF)	WJH-7-1421.pdf
Full Article (Word)	WJH-7-1421.doc
Manuscript File	15734-Review.docx
Answering Reviewers	15734-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	15734-Conflict-of-interest statement.pdf
Copyright License Agreement	15734-Copyright assignment.pdf
Peer-review Report	15734-Peer-review(s).pdf
Scientific Misconduct Check	15734-Scientific misconduct check.pdf
Scientific Editor Work List	15734-Scientific editor work list.pdf